2026-526263-38-00RecruitingPhase 1
A trial in healthy participants to find out how long JNJ-101556143 stays in and acts on the body when administered as different formulations and under different food conditions
Source: EU CTIS (euclinicaltrials.eu) · Last updated 14 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 5 May 2026
- Start date
- 19 Jun 2026
- Lead sponsor
- Janssen Cilag International
- EU CT number
- 2026-526263-38-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 48
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.